<VariationArchive RecordType="classified" VariationID="2671865" VariationName="NM_012203.2(GRHPR):c.930_931dup (p.Asn311fs)" VariationType="Duplication" Accession="VCV002671865" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-30" DateCreated="2023-12-17" MostRecentSubmission="2023-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2839392" VariationID="2671865">
      <GeneList>
        <Gene Symbol="GRHPR" FullName="glyoxylate and hydroxypyruvate reductase" GeneID="9380" HGNC_ID="HGNC:4570" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37422435" stop="37439494" display_start="37422435" display_stop="37439494" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37422706" stop="37436985" display_start="37422706" display_stop="37436985" Strand="+" />
          </Location>
          <OMIM>604296</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012203.2(GRHPR):c.930_931dup (p.Asn311fs)</Name>
      <CanonicalSPDI>NC_000009.12:37436724:TA:TATA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37436724" stop="37436725" display_start="37436724" display_stop="37436725" variantLength="2" positionVCF="37436724" referenceAlleleVCF="C" alternateAlleleVCF="CTA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37436721" stop="37436722" display_start="37436721" display_stop="37436722" variantLength="2" positionVCF="37436721" referenceAlleleVCF="C" alternateAlleleVCF="CTA" />
      </Location>
      <OtherNameList>
        <Name>c.930_931insAA</Name>
      </OtherNameList>
      <ProteinChange>N311fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.37436722_37436723dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.37436722_37436723dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.37436725_37436726dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.37436725_37436726dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008135.1" sequenceAccession="NG_008135" sequenceVersion="1" change="g.19016_19017dup">
            <Expression>NG_008135.1:g.19016_19017dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012203.2" sequenceAccession="NM_012203" sequenceVersion="2" change="c.930_931dup" MANESelect="true">
            <Expression>NM_012203.2:c.930_931dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036335.1" sequenceAccession="NP_036335" sequenceVersion="1" change="p.Asn311fs">
            <Expression>NP_036335.1:p.Asn311fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012203.2(GRHPR):c.930_931dup (p.Asn311fs) AND Primary hyperoxaluria, type II" Accession="RCV003448964" Version="2">
        <ClassifiedConditionList TraitSetID="1588">
          <ClassifiedCondition DB="MedGen" ID="C0268165">Primary hyperoxaluria, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-12-17" MostRecentSubmission="2023-12-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">35678848</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1588" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2365" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OXALOSIS II</ElementValue>
                <XRef Type="MIM" ID="260000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Primary hyperoxaluria type 2</ElementValue>
                <XRef ID="MONDO:0009824" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oxalosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glyoxylate reductase/hydroxypyruvate reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glyceric aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">D-glycerate dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
                <XRef ID="Primary+hyperoxaluria+type+2/5948" DB="Genetic Alliance" />
                <XRef ID="40951006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HP2</ElementValue>
                <XRef Type="MIM" ID="260000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PH2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Primary hyperoxaluria type 2 (PH2), caused by deficiency of the enzyme glyoxylate reductase/hydroxypyruvate reductase (GR/HPR), is characterized by recurrent nephrolithiasis (deposition of calcium oxalate in the renal pelvis/urinary tract), nephrocalcinosis (deposition of calcium oxalate in the renal parenchyma), and end-stage renal disease (ESRD). After ESRD, oxalosis (widespread tissue deposition of calcium oxalate) usually develops. Symptom onset is typically in childhood.</Attribute>
                <XRef ID="NBK2692" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000561372" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507682" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2836" />
                <XRef ID="2836" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301742</ID>
                <ID Source="BookShelf">NBK2692</ID>
              </Citation>
              <XRef ID="416" DB="Orphanet" />
              <XRef ID="93599" DB="Orphanet" />
              <XRef ID="C0268165" DB="MedGen" />
              <XRef ID="MONDO:0009824" DB="MONDO" />
              <XRef Type="MIM" ID="260000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7816338" SubmissionDate="2023-11-16" DateLastUpdated="2023-12-17" DateCreated="2023-12-17">
        <ClinVarSubmissionID localKey="NM_012203.2:c.930_931dup|OMIM:260000" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV004176771" DateUpdated="2023-12-17" DateCreated="2023-12-17" Type="SCV" Version="1" SubmitterName="Thalassemia Center, San Luigi University Hospital" OrgID="508539" OrganizationCategory="clinic" OrgAbbreviation="thal" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">35678848</ID>
          </Citation>
          <Comment>ACMG:PVS1 PM2 PM3 PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>c.930_931insAA</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.2:c.930_931dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13982728</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7816338" TraitType="Disease" MappingType="XRef" MappingValue="260000" MappingRef="OMIM">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

